The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.

A new study by UC San Francisco scientists shows that the proportion of normal cells, especially immune cells, intermixed with cancerous cells in a given tissue sample may significantly skew the results of genetic analyses and other tests performed both by researchers and by physicians ...

Keith Yamamoto, PhD, has spent his career doing basic research, and also working both to improve the practice of science and to amplify its impact beyond the walls of academia. Now, in his new role as UCSF’s first vice chancellor for Science Policy and Strategy, he’ll lead efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, both by working within the University and by influencing and shaping science policy at the state and national levels and beyond.

Nobel laureate Elizabeth Blackburn, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named the first woman president of the Salk Institute for Biological Sciences.

A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new research laboratory within the Diabetes Center at UC San Francisco devoted to understanding autoimmunity, in the hopes of laying the groundwork for new treatments for diseases ranging from type 1 diabetes to multiple sclerosis to rheumatoid arthritis.

A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.

Projects focus on quality of life, new treatment options, patient navigation and decision support, survivorship, among others.

An international team of scientists led by UC San Francisco researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer, which can be lethal when it invades other tissues in the body.

Community leader and philanthropist Helen Diller (1929-2015) received the UCSF Medal posthumously for her outstanding contributions to advancing health care and research.

At UCSF’s Institute for Human Genetics annual symposium this week, UCSF and researchers around the country gathered to honor Y.W. Kan’s contributions to science.